pilsicainide has been researched along with Recrudescence in 6 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pilsicainide is a newly synthesized antiarrhythmic agent with class Ic properties." | 6.69 | Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study. ( Aonuma, K; Azegami, K; Igawa, M; Nishizaki, M; Okishige, K; Yamawaki, N, 2000) |
| "Increased dispersion of signal-averaged P wave duration would play an important role in generating paroxysmal atrial fibrillation and would be useful in the prediction of drug efficacy to evaluate the change in dispersion by a single administration of pilsicainide." | 3.70 | Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. ( Asano, Y; Fukunami, M; Hoki, N; Hori, M; Kumagai, K; Ogita, H; Sanada, S; Shimonagata, T; Yamada, T, 1999) |
| "Pilsicainide is a newly synthesized antiarrhythmic agent with class Ic properties." | 2.69 | Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study. ( Aonuma, K; Azegami, K; Igawa, M; Nishizaki, M; Okishige, K; Yamawaki, N, 2000) |
| "Patient 1 had frequent episodes of paroxysmal atrial fibrillation resistant to Class IA drugs." | 1.30 | ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. ( Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nagasawa, H; Usui, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamakura, T | 1 |
| Wada, M | 1 |
| Nakajima, I | 1 |
| Ishibashi, K | 1 |
| Miyamoto, K | 1 |
| Okamura, H | 1 |
| Noda, T | 1 |
| Aiba, T | 1 |
| Takaki, H | 1 |
| Yasuda, S | 1 |
| Ogawa, H | 1 |
| Shimizu, W | 1 |
| Makiyama, T | 1 |
| Kimura, T | 1 |
| Kamakura, S | 1 |
| Kusano, K | 1 |
| Komatsu, T | 1 |
| Sato, Y | 1 |
| Tachibana, H | 1 |
| Nakamura, M | 1 |
| Horiuchi, D | 1 |
| Okumura, K | 1 |
| Yoshisato, T | 1 |
| Takeda, H | 1 |
| Sekiguchi, Y | 1 |
| Tsuburaya, R | 1 |
| Endo, N | 1 |
| Niitsuma, T | 1 |
| Miura, E | 1 |
| Hirosaka, A | 1 |
| Owada, K | 1 |
| Tamagawa, K | 1 |
| Yamada, T | 1 |
| Fukunami, M | 1 |
| Shimonagata, T | 1 |
| Kumagai, K | 1 |
| Sanada, S | 1 |
| Ogita, H | 1 |
| Asano, Y | 1 |
| Hori, M | 1 |
| Hoki, N | 1 |
| Fujiki, A | 1 |
| Usui, M | 1 |
| Nagasawa, H | 1 |
| Mizumaki, K | 1 |
| Hayashi, H | 1 |
| Inoue, H | 1 |
| Okishige, K | 1 |
| Nishizaki, M | 1 |
| Azegami, K | 1 |
| Igawa, M | 1 |
| Yamawaki, N | 1 |
| Aonuma, K | 1 |
2 trials available for pilsicainide and Recrudescence
| Article | Year |
|---|---|
Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy.
Topics: Adult; Age Factors; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Disease-F | 2006 |
Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Drug Admin | 2000 |
4 other studies available for pilsicainide and Recrudescence
| Article | Year |
|---|---|
Significance of electrocardiogram recording in high intercostal spaces in patients with early repolarization syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, | 2016 |
[Elderly Brugada syndrome with recurrent syncope, diagnosed by pilsicainide challenge test].
Topics: Aged; Brugada Syndrome; Electrocardiography; Humans; Lidocaine; Male; Recurrence; Syncope | 2007 |
Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; B | 1999 |
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Hea | 1999 |